Literature DB >> 12628314

Violacein and its beta-cyclodextrin complexes induce apoptosis and differentiation in HL60 cells.

Patrícia S Melo1, Giselle Z Justo, Mariângela B M de Azevedo, Nelson Durán, Marcela Haun.   

Abstract

Violacein, a pigment isolated from Chromobacterium violaceum, has been reported to have multiple biological activities including in vitro antitumor effects. Certain anticancer agents are known to induce apoptosis in human tumor cell lines. In this work, our aim was to investigate the effectiveness of violacein/beta-cyclodextrin (beta-CD)-containing systems to produce lethal effects in the human promyelocytic leukemia cell line HL60. Using the MTT tetrazolium reduction test, IC(50) for the inclusion complexes (1:1 and 1:2 violacein:beta-CD molar ratios) and violacein alone were less than 1 microM. Violacein and violacein/beta-CD complexes were able to induce NBT reduction. Moreover, by using the Feulgen reaction, all the compounds were found to trigger apoptosis in HL60 cells, inducing around 35% of DNA fragmentation, as analyzed through the diphenylamine assay. In addition, caspases seem to play an important role in the activation of the executioner phase of apoptosis induced by violacein and its derivatives.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628314     DOI: 10.1016/s0300-483x(02)00751-5

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  18 in total

1.  The use of violacein to study biochemical behaviour of Saccharomyces cerevisiae cells.

Authors:  Ricardo de Souza Pereira; Nelson Durán; Pedro L O Volpe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Oct-Dec       Impact factor: 2.441

2.  The violacein biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins.

Authors:  Katherine S Ryan; Carl J Balibar; Kaitlyn E Turo; Christopher T Walsh; Catherine L Drennan
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

3.  The antiproliferative function of violacein-like purple violet pigment (PVP) from an Antarctic Janthinobacterium sp. Ant5-2 in UV-induced 2237 fibrosarcoma.

Authors:  Nazia Mojib; Tahseen H Nasti; Dale T Andersen; Venkatram R Attigada; Richard B Hoover; Nabiha Yusuf; Asim K Bej
Journal:  Int J Dermatol       Date:  2011-07-26       Impact factor: 2.736

Review 4.  Chromobacterium violaceum and its important metabolites--review.

Authors:  M Durán; A Faljoni-Alario; N Durán
Journal:  Folia Microbiol (Praha)       Date:  2011-01-21       Impact factor: 2.099

Review 5.  Multi-target drug with potential applications: violacein in the spotlight.

Authors:  Nelson Durán; Gerson Nakazato; Marcela Durán; Ignasio R Berti; Guillermo R Castro; Danijela Stanisic; Marcelo Brocchi; Wagner J Fávaro; Carmen V Ferreira-Halder; Giselle Z Justo; Ljubica Tasic
Journal:  World J Microbiol Biotechnol       Date:  2021-08-16       Impact factor: 3.312

6.  Violacein extracted from Chromobacterium violaceum inhibits Plasmodium growth in vitro and in vivo.

Authors:  Stefanie C P Lopes; Yara C Blanco; Giselle Z Justo; Paulo A Nogueira; Francisco L S Rodrigues; Uta Goelnitz; Gerhard Wunderlich; Gustavo Facchini; Marcelo Brocchi; Nelson Duran; Fabio T M Costa
Journal:  Antimicrob Agents Chemother       Date:  2009-03-09       Impact factor: 5.191

7.  Impact of violacein-producing bacteria on survival and feeding of bacterivorous nanoflagellates.

Authors:  Carsten Matz; Peter Deines; Jens Boenigk; Hartmut Arndt; Leo Eberl; Staffan Kjelleberg; Klaus Jürgens
Journal:  Appl Environ Microbiol       Date:  2004-03       Impact factor: 4.792

8.  Isolation and characterization of two groups of novel marine bacteria producing violacein.

Authors:  Shuichi Yada; Yi Wang; Yanshuang Zou; Keiko Nagasaki; Kakushi Hosokawa; Issey Osaka; Ryuichi Arakawa; Keiich Enomoto
Journal:  Mar Biotechnol (NY)       Date:  2007-10-30       Impact factor: 3.619

9.  Comparative Study of Bacterial Communities in Nepenthes Pitchers and Their Correlation to Species and Fluid Acidity.

Authors:  Pattanop Kanokratana; Wuttichai Mhuanthong; Thanaporn Laothanachareon; Sithichoke Tangphatsornruang; Lily Eurwilaichitr; Trongtham Kruetreepradit; Shawn Mayes; Verawat Champreda
Journal:  Microb Ecol       Date:  2016-06-10       Impact factor: 4.552

10.  New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles.

Authors:  Mariangela de Burgos M de Azevedo; Ljubica Tasic; Juliana Fattori; Fábio H S Rodrigues; Fabiana C Cantos; Leandro P Ribeiro; Vanice de Paula; Danielle Ianzer; Robson A S Santos
Journal:  Int J Nanomedicine       Date:  2011-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.